Olmesartan blocks advanced glycation end products (AGEs)-induced angiogenesis in vitro by suppressing receptor for AGEs (RAGE) expression

scientific article published on 18 May 2007

Olmesartan blocks advanced glycation end products (AGEs)-induced angiogenesis in vitro by suppressing receptor for AGEs (RAGE) expression is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/J.MVR.2007.05.001
P698PubMed publication ID17560613

P2093author name stringKazuo Nakamura
Hiroyoshi Inoue
Takanori Matsui
Tsutomu Imaizumi
Masayoshi Takeuchi
Kei Fukami
Seiya Okuda
Sho-ichi Yamagishi
Seiji Ueda
P433issue1
P921main subjectangiogenesisQ539568
P304page(s)130-134
P577publication date2007-05-18
P1433published inMicrovascular ResearchQ15752704
P1476titleOlmesartan blocks advanced glycation end products (AGEs)-induced angiogenesis in vitro by suppressing receptor for AGEs (RAGE) expression
P478volume75

Reverse relations

cites work (P2860)
Q37986418A novel improved therapy strategy for diabetic nephropathy: targeting AGEs
Q89849564Association of candidate gene polymorphisms with diabetic retinopathy in Chinese patients with type 2 diabetes
Q37328633Association of the receptor for advanced glycation end products gene polymorphisms and circulating RAGE levels with diabetic retinopathy in the Chinese population
Q34355343Candesartan attenuates diabetic retinal vascular pathology by restoring glyoxalase-I function
Q35754513Direct Renin Inhibition with Aliskiren Improves Ischemia-Induced Neovasculogenesis in Diabetic Animals via the SDF-1 Related Mechanism
Q37626348Effect of N-acetylcysteine on the early expression of inflammatory markers in the retina and plasma of diabetic rats
Q87425230Effect of advanced glycosylation end products (AGEs) on proliferation of human bone marrow mesenchymal stem cells (MSCs) in vitro
Q42009075Hypertension induces brain β-amyloid accumulation, cognitive impairment, and memory deterioration through activation of receptor for advanced glycation end products in brain vasculature
Q89558541Identifying Synergistic Mechanisms of Multiple Ingredients in Shuangbai Tablets against Proteinuria by Virtual Screening and a Network Pharmacology Approach
Q41789363Involvement of TAGE-RAGE System in the Pathogenesis of Diabetic Retinopathy
Q37678807Mediators of ocular angiogenesis
Q36373255Predictive value of advanced glycation end products for the development of post-infarction heart failure: a preliminary report.
Q38858414Role of Moesin in Advanced Glycation End Products-Induced Angiogenesis of Human Umbilical Vein Endothelial Cells
Q84661769Role of advanced glycation end product receptors in the pathogenesis of diabetic retinopathy
Q27010462Role of receptor for advanced glycation end products (RAGE) in liver disease
Q33852213Toxic AGE (TAGE) Theory for the Pathophysiology of the Onset/Progression of NAFLD and ALD
Q27028225Vitreous mediators in retinal hypoxic diseases

Search more.